|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,079,680 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,018,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-06-04 |
4 |
S |
$62.52 |
$62,521 |
D/D |
(1,000) |
178,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
226,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-12 |
4 |
S |
$81.51 |
$81,513 |
D/D |
(1,000) |
228,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-16 |
4 |
AS |
$123.48 |
$123,477 |
I/I |
(1,000) |
35,258 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-17 |
4 |
AS |
$124.87 |
$124,866 |
I/I |
(1,000) |
34,258 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-20 |
4 |
AS |
$126.40 |
$126,396 |
I/I |
(1,000) |
33,258 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-09-14 |
4 |
AS |
$131.43 |
$131,432 |
I/I |
(1,000) |
27,758 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-10-15 |
4 |
AS |
$108.24 |
$108,241 |
I/I |
(1,000) |
26,758 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-11-30 |
4 |
AS |
$94.74 |
$94,744 |
I/I |
(1,000) |
25,758 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-04-07 |
4 |
AB |
$139.48 |
$139,480 |
D/D |
1,000 |
2,177 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-04-13 |
4 |
AB |
$139.66 |
$139,660 |
D/D |
1,000 |
3,177 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-02 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
273,216 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-22 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
297,106 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-26 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
285,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-27 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
286,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-04-02 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
289,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-04-05 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
290,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-06-13 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
285,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-09-25 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
286,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-10-24 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
287,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-10-30 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
288,290 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2018-11-08 |
4 |
B |
$68.62 |
$68,765 |
D/D |
1,000 |
6,668 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-19 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
336,338 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-27 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
324,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-11 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
325,211 |
0 |
- |
|
852 Records found
|
|
Page 6 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|